申请人:Aileron Therapeutics, Inc.
公开号:US20140135255A1
公开(公告)日:2014-05-15
The present invention provides biologically active crosslinked polypeptides with improved properties relative to their corresponding precursor polypeptides, having good cell penetration properties and reduced binding to human proteins. The invention additionally provides methods of identifying and making such improved polypeptides.